McDonald’s Corp Decides to Curb the Use of Antibiotics in it Chicken Supply Globally
McDonald’s Corp on 23rd of August 2017 (Wednesday) declared that it will start cutting and limiting the use of antibiotics with high value in its chicken supply across the globe from 2018. The popular fast-food giant has decided to contribute towards a broad effort of battling perilous superbugs. In a legal policy statement, McDonald’s stated that it has started working on antibiotic strategies for other types of meats, laying hens, and dairy cows. The fast-food chain is suggesting chicken meat suppliers to start phasing the usage of antibiotics determined by the WHO (World Health Organization) as HPCIA (highest priority critically important antimicrobials) to human medication.
Consumer groups and Public health groups have applauded and appreciated the move, which does not seem to be as strict and rigorous as the firm’s policy mainly for the United States. In the U.S, it’s been more than a year that suppliers have been providing the fast-food chain with chickens that are raised without any antibiotics considered essential to human health.
From January 2018, Highest Priority Critically Important Antimicrobials (HPCIA) will be eliminated from McDonald’s chicken in South Korea, Japan, Canada, Brazil, Europe, and the United States. Only in European countries, McDonald’s is planning to use an exception namely Colistin- a last option for antibiotics. As 2019 ends, suppliers in Russia and Australia will stop making use of European suppliers and HPCIAs plan to eliminate Colistin. Moreover, suppliers from all other markets shall follow the process from January 2027, according to reliable sources associated with the matter.
In the antibiotic policy update posed by McDonald’s, the company mentioned that, “Our aim is to get this policy executed before this date.” The company told a team of environmental organizations and consumers on 17th August 2017, that seventy four percent of its universal chicken sales are decided to abide by this policy effective from January 2018. The policy department of consumer reports confirmed the statement.
You may be interested
Amebiasis Treatment Market to Grow Like Never Before By 2026Albert R - August 18, 2018
Amebiasis Treatment Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…
Gamma Probe Device Market to Grow Like Never Before By 2026Albert R - August 18, 2018
Gamma Probe Device Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market…
Metastatic Osteosarcoma Treatment Market – Latest AdvancementsAlbert R - August 18, 2018
Metastatic Osteosarcoma Treatment Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market…